AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus: AbbVie's Allergan and Evolus have been locked in a yearslong trade secrets fight involving the two drugmakers' South Korean partners and blockbuster Botox. Despite some early signs in Evolus' favor, a U.S. trade judge has now flipped the script on the California drugmaker's underdog Botox challenger.
No comments:
Post a Comment